Drawing for ERIGEN

USPTO serial 88933620

ERIGEN

Reviewed by CopyMark Law Group

Reg. 6280633Status 700Renewal
Filing date
Status date
Registration date
Mar 2, 2021
Examiner
FINK, GINA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ERIGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rachelle A. Dubow, Esq.

RACHELLE A. DUBOW, ESQ. MORGAN, LEWIS & BOCKIUS LLPONE FEDERAL STREETBOSTON, MA 02110UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Pharmaceutical research and development services in the field of production of cell therapies, with or without gene-editing and with or without mRNA engineering; pharmaceutical research and development services, in the field of gene-editing, mRNA engineering, cell reprogramming, and cell therapy developmentACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 2, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 2, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 15, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 15, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 25, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 12, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 12, 2020XAECEXAMINER'S AMENDMENT ENTERED
Nov 12, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 12, 2020GNEAEXAMINERS AMENDMENT E-MAILED
Nov 12, 2020CNEAEXAMINERS AMENDMENT -WRITTEN
Aug 28, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 28, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 28, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 26, 2020DOCKASSIGNED TO EXAMINER
Jun 12, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 29, 2020NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance